Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial
JMIR Mental Health · 2025-02-05 · 12 · e63515
DOI: 10.2196/63515 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Mental Health, published online on 2025-02-05. Written by Anne Marijn de Graaff and 12 co-authors. Institution: Department of Mental Health, Brain Health and Substance Use, World Health Organization, Geneva, Switzerland. Major MEDLINE topics: Cognitive Behavioral Therapy, Depression, Anxiety, Stress, Psychological. Cited 14 times so far (Crossref); 47 references. The full text is freely available in PubMed Central. Funded by: World Health Organization.
Abstract (original language)
Background
Depression and anxiety are a leading cause of disability worldwide and often start during adolescence and young adulthood. The majority of young people live in low- and middle-income countries where there is a lack of mental health services. The World Health Organization (WHO) developed a guided, nonartificial intelligence chatbot intervention called Scalable Technology for Adolescents and youth to Reduce Stress (STARS) to reduce symptoms of depression and anxiety among young people affected by adversity.
Objective
The objective of this study was to evaluate the feasibility of the STARS intervention and study procedures among young people in Jordan.
Methods
A 2-arm, single-blind, feasibility randomized controlled trial was conducted among 60 young people aged 18 years to 21 years living in Jordan with self-reported elevated levels of psychological distress. Immediately after baseline, participants were randomized 1:1 into the STARS intervention or enhanced care as usual (ECAU). STARS consisted of 10 lessons in which participants interacted with a chatbot and learned several cognitive behavioral therapy strategies, with optional guidance by a trained e-helper through 5 weekly phone calls. ECAU consisted of a static web page providing basic psychoeducation. Online questionnaires were administered at baseline (week 0) and postassessment (week 8) to assess depression (Hopkins Symptom Checklist-25 [HSCL-25]), anxiety (HSCL-25), functional impairment (WHO Disability Assessment Schedule [WHODAS] 2.0), psychological well-being (WHO-Five Well-Being Index [WHO-5]), and agency (State Hope Scale). Process evaluation interviews with stakeholders were conducted after the postassessment.
Results
Participants were recruited in December 2022 and January 2023. Of 700 screening website visits, 160 participants were eligible, and 60 participants (mean age 19.7, SD 1.16 years; 49/60, 82% female) continued to baseline and were randomized into STARS (n=30) or ECAU (n=30). Of those who received STARS, 37% (11/30) completed at least 8 chatbot lessons, and 13% (4/30) completed all 5 support calls. The research protocol functioned well in terms of balanced randomization, high retention at postassessment (48/60, 80%), and good psychometric properties of the online questionnaires. Process evaluation interviews with STARS participants, ECAU participants, e-helpers, and the clinical supervisor indicated the acceptability of the study procedures and the STARS and ECAU conditions and highlighted several aspects that could be improved, including the e-helper support and features of the STARS chatbot.
Conclusions
This study demonstrated the feasibility and acceptability of the STARS intervention and research procedures. A fully powered, definitive randomized controlled trial will be conducted to evaluate the effectiveness of STARS. Trial Registration ISRCTN ISRCTN19217696; https://doi.org/10.1186/ISRCTN19217696
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Mental Health, Brain Health and Substance Use, World Health Organization, Geneva, Switzerland.
- Institute for Family Health, King Hussein Foundation, Amman, Jordan.
- School of Psychology, University of New South Wales, Sydney, Australia.
- Department of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Stockholm, Sweden.
- Community Health Nursing Department, School of Nursing, University of Jordan, Amman, Jordan.
ORCID profiles: Anne Marijn de Graaff, Rand Habashneh, Sarah Fanatseh, Dharani Keyan, Aemal Akhtar, Adnan Abualhaija, Muhannad Faroun, Ibrahim Said Aqel, Latefa Dardas, Chiara Servili, Mark van Ommeren, Richard Bryant, Kenneth Carswell
Funding
- World Health Organization
Cite
APA
de Graaff, A. M., Habashneh, R., Fanatseh, S., Keyan, D., Akhtar, A., Abualhaija, A., Faroun, M., Aqel, I. S., Dardas, L., Servili, C., van Ommeren, M., Bryant, R., & Carswell, K. (2025). Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial. JMIR Mental Health, 12, e63515. https://doi.org/10.2196/63515
Vancouver
de Graaff AM, Habashneh R, Fanatseh S, Keyan D, Akhtar A, Abualhaija A, et al. Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial. JMIR Mental Health. 2025;12:e63515. doi:10.2196/63515
BibTeX
@article{deGraaff2025,
author = {de Graaff, Anne Marijn and Habashneh, Rand and Fanatseh, Sarah and Keyan, Dharani and Akhtar, Aemal and Abualhaija, Adnan and Faroun, Muhannad and Aqel, Ibrahim Said and Dardas, Latefa and Servili, Chiara and van Ommeren, Mark and Bryant, Richard and Carswell, Kenneth},
title = {Evaluation of a Guided Chatbot Intervention for Young People in Jordan: Feasibility Randomized Controlled Trial},
journal = {JMIR Mental Health},
year = {2025},
volume = {12},
pages = {e63515},
doi = {10.2196/63515}
}
EUVIMED